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IMPORTANCE Interpreting screeningmammograms is a difficult repetitive task that can result
in missed cancers and false-positive recalls. In the United Kingdom, 2 film readers
independently evaluate eachmammogram to search for signs of cancer and examine digital
mammograms in batches. However, a vigilance decrement (reduced detection rate with time
on task) has been observed in similar settings.
OBJECTIVE To determine the effect of changing the order for the second film reader of
batches of screeningmammograms on rates of breast cancer detection.
DESIGN, SETTING, AND PARTICIPANTS Amulticenter, double-blind, cluster randomized clinical
trial conducted at 46 specialized breast screening centers from the National Health Service
Breast Screening Program in England for 1 year (all between December 20, 2012, and
November 3, 2014). Three hundred sixty readers participated (mean, 7.8 readers per
center)—186 radiologists, 143 radiography advanced practitioners, and 31 breast clinicians, all
fully qualified to report mammograms in the NHS breast screening program.
INTERVENTIONS The 2 readers examined each batch of digital mammograms in the same
order in the control group and in the opposite order to one another in the intervention group.
MAIN OUTCOMES ANDMEASURES The primary outcomewas cancer detection rate; secondary
outcomes were rates of recall and disagreements between readers.
RESULTS Among 1 194 147 women (mean age, 59.3; SD, 7.49) who had screening
mammograms (596642 in the intervention group; 597 505 in the control group), the images
were interpreted in 37 688 batches (median batch size, 35; interquartile range [IQR]; 16-46),
with each reader interpreting a median of 176 batches (IQR, 96-278). After completion of all
subsequent diagnostic tests, a total of 10 484 cases (0.88%) of breast cancer were detected.
There was no significant difference in cancer detection rate with 5272 cancers (0.88%)
detected in the intervention group vs 5212 cancers (0.87%) detected in the control group
(difference, 0.01% points; 95% CI, −0.02% to 0.04% points; recall rate, 24 681 [4.14%] vs
24 894 [4.17%]; difference, −0.03% points; 95% CI, −0.10% to 0.04% points; or rate of
reader disagreements, 20 471 [3.43%] vs 20 793 [3.48%]; difference, −0.05% points;
95% CI, −0.11% to 0.02% points).
CONCLUSIONS AND RELEVANCE Interpretation of batches of mammograms by qualified
screeningmammography readers using a different order vs the same order for the second
reading resulted in no significant difference in rates of detection of breast cancer.
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B reast cancer screening detects 8.6 cancers per thou-sandwomenscreened triennially (equivalent to 18000cancers per year) in theUnitedKingdom,1 and4.2 can-
cers per thousand women screened annually in the United
States.2 However, another 2.9 cancers per thousand women
screened in the United Kingdom3 (equivalent to 6030 can-
cers per year)1 and0.9 cancers per thousandwomen screened
in theUnited States aredetectedbetween screening rounds in
screened women.2 These arise through cancers growing be-
tween screening rounds, and cancersmissed at screening. An
additional 3.3%ofwomen in theUnitedKingdom(69700each
year)1 and 9.3% of women in the United States2 experience
false-positive recalls at each screening round.
Interpreting screeningmammograms is a difficult and re-
petitive visual search task, forwhich characteristics of cancer
are disguised among background breast parenchyma result-
ing in false-positive recalls andmissed cancers. In similar vi-
sual search tasks, a vigilance decrement of decreasing detec-
tionrateswithtimeontaskhasbeenobserved ina largenumber
of psychological laboratory experiments,4,5 for example, as-
sembly line inspection tasks,6 airport baggage screening,7
driving,8 piloting airplanes,9 andoperatingmilitary drones.10
An effect similar to the vigilance decrement has been ob-
served when examining tests sets of x-rays including mam-
mograms in laboratory conditions although the phenom-
enon has not previously been explored in breast screening
practice.11,12
In the United Kingdom, 2 film readers independently ex-
amineeachwoman’smammograms for signsof cancer. In this
study, we investigated whether a vigilance decrement to de-
tect cancer in breast screening practice exists and whether
changing the order inwhich the 2 experts examined thebatch
of mammograms could increase the cancer detection rate,
throughreaders’ experiencingpeakvigilanceatdifferingpoints
within the reading batch when examining different women’s
mammograms.
Methods
Study Design
The Changing Case Order to Optimise Patterns of Perfor-
mance inScreening (CO-OPS), apragmatic, double-blind, clus-
ter randomizedclinical trial,measuredwhetheravigilancedec-
rement inbreast cancer screeningexists andwhether changing
case order can increase cancer detection.
Ethical approval was granted by the Coventry and
Warwickshire National Health Service (NHS) Research Ethics
Committee on June 27, 201212 (WM/0182). Each director of
breast screening provided written informed consent. The
trial protocol is provided in Supplement 1 and published
elsewhere.13 The statistical analysis plan was finalized before
any data were collected (Supplement 2) .
Intervention andOutcomes
The study compared 2 parallel groups, each split into 2 sub-
groups to ensure blinding of the readers. The intervention
group involved the 2 readers reviewing the batch in the op-
posite order of each other; 1 forward, 1 in reverse. Hence, the
2 subgroups: first reader forward, second reader reverse, and
first reader reverse, second reader forward. The control group
required the readers to read thebatch in the sameorderaseach
other; the subgroups being either both forward (which is cur-
rent practice) or both in reverse (tomaintain the blinding of a
reader to trial group because the readerswould be aware that
theywere reading a batch in reverse). Thus, each batch (clus-
ter) was randomized with equal probability to 1 of 4 groups.
The primary outcome was cancer detection rate, (num-
ber of women with cancer detected as a proportion of all
women screened) because this is the clinically relevant out-
come of interest. Secondary outcomes of recall rate (second-
ary outcome 1) and rate of disagreement between the readers
(secondary outcome 2) are designed to examine the pro-
posedmechanism of action. The idea is that reversing the or-
der for 1 reader results in high-vigilance states occurring for
the 2 readers when examining different women’s mammo-
grams, so the cancers are detected by at least 1 of the experts,
as outlined in Figure 1. If a reader in a high-vigilance state de-
tected a cancermissed by his/her colleague in a low-vigilance
state, then this would lead to a disagreement between them.
All disagreements are arbitrated either by a third reader or
group of readers for the final decision ofwhether to recall the
woman for further tests.Assuming thearbitrationprocessper-
forms better than random chance the increases in disagree-
mentswould lead to increases in recall rate and cancer detec-
tion rate.
Participants
Centerswere recruitedat radiologymeetings, through local ra-
diology, radiography,andqualityassurancegroupsandthrough
direct telephone and email contact. The study comprised 46
breast screeningcentersusingdigitalmammography,eachcon-
sistingof groupsof between 1 and3hospitals sharing the same
computer system for storing women’s health records. Char-
acteristics of breast screening centers in England that partici-
pated in the trial compared with those that did not is pro-
vided in eTable 1 in Supplement 2. The trial ran for 1 year at
each center, with individual centers starting the study when
local consent and research and development approvals were
obtained, (startdateswereall betweenDecember20,2012, and
November 3, 2014). One center completed only 4 months of
the study due to local technical and workforce issues.
Mammograms fromwomenattending routine breast can-
cer screening at these centers during the studyperiodwere in-
cluded.Thesewere arranged intobatchesof approximately40
womenpursuant to standard practice in theUnitedKingdom.
All mammograms taken during the study period were in-
cludedinthetrial, regardlessofwhentheywereexamined.Each
batch contained all cases from a single mammography acqui-
sitionmachine inasingleday. Informedconsentwasat thecen-
ter level, with consent of individual women considered im-
practical for this system-level intervention. In the United
Kingdom, women aged 50 to 70 years are invited to breast
screening every 3 years. This study also includeswomen aged
47 through49 years and 71 through 73 yearswhowere partici-
pating in theageextensiontrial (NCT01081288),andasmallpro-
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portion of olderwomen (2.3%ofwomen in the trial) who self-
refer as part of the program.Womenwho presented to clinics
symptomatically and for high-familial riskwere excluded.
All readers undergo formal training and are accredited by
the NHS Breast Screening Programme. They are required to
read aminimumof 5000 cases per year, participate in assess-
ment clinics, formally audit their own performance against
their peers, andmaintain ongoing professional development
including participating annually in the Personal Performance
in Mammographic Screening test set.14 Each center annually
measures and reports results against targets including recall
rate, cancer detection rate, and small-cancer detection rate,
and continuously audits performance through monthly re-
view of interval cancers diagnosed symptomatically be-
tween screening rounds,14 andmonthly checks of mammog-
raphy acquisition and display equipment and reading room
background light levels.15Eachwoman’smammogramsareex-
aminedby2 readers located in the samebreast screening cen-
ter. Readers are instructed to examine the batches indepen-
dently, but can access the other reader’s decision by opening
the patient records. In 16 of the 46 centers, workflow systems
were designed to blind reader 2 to the decision of reader 1. All
centers used arbitrationwhen the2 readers disagreed,with 13
centers using a single third reader, and 33 centers using group
consensus of 2 or more readers.
Randomization and Blinding
The randomization took place immediately prior to opening
each batch for examination using the Intersystems Caché
$RANDOMfunctionwithin the computer software that theUK
National Breast Screening Service (NBSS) uses tomanage the
work. After randomization the software automatically dis-
played the cases in the chosen order to the first and second
reader. Readers were aware of the reading order but were
blinded to trial group. The trial statistician and the women
screenedwere alsoblinded to trial group. Theunit of random-
ization was a batch of mammograms, whereas the unit of
observationwas the individualmammogram.Simple random-
Figure 1. ProposedMechanism of Action of Changing Case Order Intervention, Assuming the Hypothesized
Vigilance Decrement
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Each screening represents examining
a set of 4mammograms,
mediolateral oblique and
craniocaudal views of both breasts
for one woman.
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ization was used without stratification or minimization due
to the large number of clusters randomized.
Data Collection
The data were collected via an adaptation to the NBSS com-
puter system, which created new tables within the software
to record data items pertaining to the trial. The outcomes for
everywomanscreened (includingboth readers’ decision, time
of decision, and results of all follow-up tests including bi-
opsy) were added to NBSS as part of each center’s annual re-
porting requirements to reduce missing data. The data were
extracted through NBSS from each center, exporting data in
Excel format.Thedatasets fromeachcenterweremergedusing
Excel and R (version 3.0.3 in RStudio version 0.98.501). Can-
cerwasdefinedasneedlebiopsyor surgerysamples that tested
positive for ductal carcinoma in situ or invasive cancer. Re-
call for further testswas takendirectly fromNBSS,which rec-
ords this decision to enable the follow-up appointment to be
made. Disagreement was defined by examining whether the
recommendationofwhether to recalldifferedbetweenthe first
and second readers.
Sample Size
Prior to the study (year 2011-2012) the breast cancer detec-
tion rate in theUnitedKingdomwas 7.8 per thousandwomen
screened.16 Three years of observational data on patterns of
cancer detection with time on task was extracted from rou-
tine records at 8 breast screening centers in 1 English region.
This suggested that the interventionmay result in 1 extra can-
cer detectedper 2000womenscreened, an increase to8.3 per
thousand women screened. To detect such an increase re-
quired a sample size of 501 361 women in each group, using a
5% significance level and 80% power. The trial had a cluster
design, the unit of randomization being the batch, so the
sample size needed to be inflated by the design effect. The in-
tercluster correlation coefficient was estimated to be 0.002,
resulting in a design effect of 1.09, assuming an average clus-
ter size of 40. Hence, the total sample size required was
1093780,which isequivalent to theannual caseloadof44cen-
ters. There were no interim analyses or stopping rules.
Statistical Analysis
We used multivariable multilevel logistic regression to ana-
lyze factors associatedwithbreast cancerdetection, recall, and
disagreement rates due to the hierarchical nature of the data
sets. Analysis was intention to treat, with those not receiving
the intervention as allocated included in the analysis. How-
ever, women lost to follow-up, technical recalls (mammo-
gramswereof insufficient quality to read), and secondscreen-
ingof thesamewomanwereexcluded.A three-levelmultilevel
model forwoman screened (level 1) nested in a batch (level 2)
andwithin a center (level 3) was specified. Fourmodels were
constructed for each of the rates as stated above. The first
model, a nullmodelwithout any variablewas specified to de-
compose the amountof variance that existedat each level, the
secondmodel included the interventiononly, the thirdmodel
included adjustment for known factors associated with can-
cer and recall (woman’s age and whether she had previously
attended screening), whereas the fourthmodel added the in-
tervention to the adjustedmodel.Allmultilevelmodelingwas
performedusingMlwiN2.3517 called fromStata statistical soft-
ware forWindowsversion1418using the runmlwin routine.For
the multilevel logistic regression models, (iterative general-
ized least squares; penalized quasi-likelihood) IGLS PQL2
estimation was used.19 Two-tailed tests were used, with
Pvalues<.05consideredsignificant.The fixedeffects (ie,mea-
suresofassociation)arepresentedasadjustedoddsratios (ORs)
with their corresponding 95% CIs. Measures of random ef-
fects included intracluster correlation (ICC) andmedian odds
ratio (MOR).20 The ICCwas calculated by the linear threshold
according to the formulausedbySnijders et al,21whereasMOR
is a measure of unexplained cluster heterogeneity. Methods
used for calculatingMORhavebeendescribedelsewhere.20,22
Positive predictive value was also calculated in the interven-
tion and control groups as the proportion of recalled cases in
which cancer was detected.
The samemodels were constructed for 3 predefined sub-
groups:womenyounger than53years (inwhomthe interven-
tion may be more effective due to higher breast density in-
creasing the task difficulty); the first and last 5 cases in each
batch (inwhichanydifference invigilancewouldbeat itsmaxi-
mum in the intervention group); and the first batch of the day
(toexaminewhether theeffectivenessof the interventionmay
bemasked by examining a number of batches in succession).
Anexploratorypost hoc subgroupanalysis of cases,which are
not in the first batchof theday for either reader, used the same
modelstructure (to investigate interventioneffectivenesswhen
readers may be fatigued).
An exploratory post hoc analysis to measure whether
there is a vigilance decrement of decreasing sensitivity to
detect cancer with time spent on task, the position in the
batch (ie, first, second, third…) was added as a variable to
the unadjusted and adjusted models of cancer detection out-
lined above. For this analysis the cancer detection rate
outcome was personalized to the individual reader who
first examined the case, so the outcome had an additional
requirement of being correctly identified by the first reader
for recall, as well as having cancer identified on follow-up
tests. The samemodeling approach was applied to recall rate,
to measure any systematic change with time on task. In this
case, it was the recall rate for the first reader, rather than
overall from the process that was analyzed. Further explor-
atory post hoc analysis was conducted to determine whether
the lack of effect of the intervention was associated with
reader 2 not being blinded to the decision of reader 1 at some
trial centers. Including only the subgroup of centers in which
reader 2 was blinded to the decision of reader 1, cancer detec-
tion rates and recall rates in the intervention group were cal-
culated, and compared with those in the control group.
Results
Flow ofWomen in the Trial
Atotal of 1 207633womenwere included in the trial (Figure2).
There were 3 causes of loss to follow up: 258 (0.02%) were
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recalled for further tests fromscreeningbutdidnotattend,233
(0.02%) had an inconclusive needle biopsy test result but re-
fused further tests, and 298 (0.02%) had missing data in the
NBSS system. An additional 12 426 cases (1.03%)were judged
of insufficient quality for analysis (technical recall) by the first
reader so were not read within batch and could not be in-
cluded in the analysis, and 271 (0.02%) cases were excluded
because the samewomanhadalreadybeen screened that year
and included in the trial. Thisoccurredprimarilywhenwomen
whohadchangedprimary carepractice aftermoving andcon-
sequently were reinvited more quickly than intended.
The intervention and control groups were well matched
for baseline characteristics including the age andprevious at-
tendance of the women screened and batch length, as de-
tailed in Table 1. Mammogramswere examined by 360 quali-
fied readers, of which 186 were radiologists, 143 were
radiography advanced practitioners, and 31were breast clini-
cians. The median batch length was 35 cases (interquartile
range [IQR], 16-46). Each reader examined a median of 5640
cases, (IQR, 2599-8458), in a median of 176 batches (IQR,
96-278), including cases in both the intervention and control
groups. Between 1 and 26 batches were examined by each
reader in a single day (median, 2; IQR, 1-4). Each center exam-
ined between 8152 and 72 714 cases (median, 25 540 cases).
Outcomes
Theprimaryoutcome, cancerdetection rate,was0.88%(5272
of 596 642) in the intervention group and 0.87% (5212 of
597 505) in the control group (difference, 0.01% points; 95%
CI, −0.02% to0.04%;Table 2). The interventiondidnot affect
the cancer detection rate in the unadjusted (OR, 1.01; 95%CI,
0.96-1.06) or adjusted models (OR, 1.01; 95% CI, 0.97-1.06;
Table 3 and eTables 2 and 3 in Supplement 2). In the adjusted
model, cancer detection rate increased with each increasing
year of age (OR, 1.052; 95%CI, 1.048-1.055) andwas higher in
womenwhohadnot previously attended screening (OR, 1.73;
95% CI, 1.62-1.86). The intervention also had no effect in any
of the subgroups of younger age, first and last 5 cases in the
Figure 2. Study Flow of Trial Comparing Same vs Different Order for Presenting Batches ofMammograms
to Breast Screening Readers
80 Breast screening centers in England
34 Excluded
6 Declined participation
6 Did not meet eligibility criteria
22 Not successfully contacted
4 Not interested
2 Already using intervention
18 797 Batches randomized to the intervention group 
(603 528 screenings; batch size: mean, 32.1;
median, 35; range, 1-107)
523 781 Screenings read according to intervention
79 747 Screenings not read according to intervention
but included in the primary analysis b 
895 Only 1 reader
16 952 Used bar code instead of ordered list
1 Not read
51 599 Not read in intended order
26 110 Trainee reader
1 Results entered by administrator
not reader
596 642 Screenings included in the primary analysis
(18 799 batches: batch size, mean 31.8;
median, 35; range, 1-106)
6481 Screenings excluded from the primary analysis
405 No follow-up
6339 Technical recall
142 Duplicate screen from same patient
405 Screenings without follow-up
172 NBSS records not updated c
115 Inconclusive biopsy results and
did not schedule appointment
118 Recalled but did not schedule an
appointment 
18 927 Batches randomized to the control group 
(604 105 screenings; batch size: mean,
31.9; median, 35; range, 1-111)
559 004 Screenings read according to intervention
45 101 Screenings not read according to intervention
but included in the primary analysis b 
40 528 Not read in intended order
625 Only 1 reader
17 176 Used bar code instead of ordered list
1 Results entered by administrator
not reader
597 505 Screenings included in the primary analysis
(18 909 batches: batch size, mean 31.6;
median, 34; range, 1-110)
6216 Screenings excluded from the primary analysis
384 No follow-up
6087 Technical recall
129 Duplicate screen from same patient
384 Screenings without follow-up
126 NBSS records not updated c
118 Inconclusive biopsy results and
did not schedule appointment
140 Recalled but did not schedule an
appointment 
37 724 Batches of mammograms randomized
at 46 centers (1 207 633 screenings a;
batch size: mean, 32; median,
35; range, 1-111)
a Each screening included 4
mammograms (mediolateral
oblique and craniocaudal views of
both breasts).
b For each screening, there may be
multiple reasons why they did not
receive the allocated intervention.
c National Breast Screening Service
(NBSS) records are the electronic
health records of women screened.
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batch, the first batch of the day for both readers, or in batches
examined second in the day or later by both readers in either
the adjusted or unadjusted models. For batches read first in
eachworkdaybybothreaders, cancerdetectionratewas0.83%
(580of70071;95%CI,0.76%-0.89%) in the interventiongroup
and 0.88% (623 of 70 715; 95% CI, 0.81%-0.95%) in the con-
trol group (difference, −0.05% points; 95% CI, −0.15%-
0.04%points). For batches read secondor subsequent in each
workdaybyboth readers, the cancer detection ratewas0.85%
(2472 of 289 786; 95% CI, 0.82%-0.89%) in the intervention
group and 0.85% (2473 of 290671; 95% CI, 0.82%-0.88%) in
thecontrolgroup (difference,0.002%points;95%CI,−0.045%
to 0.050% points).
The interventiondidnotaffect eitherof thesecondaryout-
comes, recall rate, or rateofdisagreements. The recall ratewas
4.14% (24681 of 596642) in the intervention groupand4.17%
(24894 of 597 505) in the control group (difference, −0.03%
points; 95% CI, −0.10% to 0.04% points; Table 2). The rate of
disagreement was 3.43% in the intervention group (20471 of
596294) and 3.48% (20793 of 597 387) in the control group
(difference, −0.05% points; 95% CI, −0.11% to 0.02% points;
Table 2). The intervention had no effect on recall rate in the
unadjusted (OR, 0.993; 95% CI, 0.974-1.013) or adjusted (OR,
0.99795%CI, 0.978-1.016)models (eTable 1 in Supplement 2)
or on the rate of disagreement in the unadjusted (OR, 0.994;
95% CI, 0.971-1.019) or adjusted model (OR, 0.997; 95% CI,
0.974-1.020; eTable4 inSupplement2). Recall ratewashigher
with each year of age of thewoman screened (OR, 1.008; 95%
CI, 1.007-1.010), and was higher in women who had not pre-
viously attended breast screening (OR, 2.89; 95% CI, 2.82-
2.97). Rateofdisagreementwas alsohigher forwomenat their
first screening appointment (OR, 2.17; 95% CI, 2.11-2.24) but
lowerwith eachyear of increasing ageof thewoman screened
(OR,0.994;95%CI,0.992-0.996).Thepositivepredictivevalue
(PPV) was 21.4% (95% CI, 20.8%-21.9%) in the intervention
group and 20.9% (95% CI, 20.4%-21.4%) in the control group
(difference,0.42%points;95%CI,−0.30%to1.14%points).The
intervention had no effect on any of the subgroups (younger
women, first and last cases in the batch, first batch of the day,
and second or subsequent batch of the day) for either the ad-
justedorunadjustedmodels for either recall rate or rateofdis-
agreements. For batches read first in each workday by both
readers, the recall rate was 4.02% (2818 of 70071; 95% CI,
3.88%-4.17%) in the intervention group and 4.11% (2904 of
70 715, 95% CI, 3.96%-4.25%) in the control group (differ-
ence, −0.08% points; 95% CI, −0.29% to 0.12% points), and
rateofdisagreementswas3.61%(2531of70071;95%CI,3.47%-
3.75%) in the interventiongroupand3.75%(2653of70715;95%
CI, 3.61%-3.89%) in the control group (difference, −0.14%
points;95%CI,−0.34%-0.06%points).Forbatches readsecond
Table 2. Primary and Secondary Outcomes in Intervention and Control Groups Overall and by Previous Screening Attendancea
Outcome
Intervention Control
Difference, % points (95% CI)No./Total % (95% CI) No./Total % (95% CI)
Primary Outcome: Cancer Detection Rate
All screenings 5272/596 642 0.88 (0.86 to 0.91) 5212/597 505 0.87 (0.85 to 0.90) 0.01 (−0.02 to 0.04)
Previous attenders 4214/470 152 0.90 (0.87 to 0.92) 41 22/469 288 0.88 (0.85 to 0.91) 0.02 (−0.02 to 0.06)
Previous nonattenders 1058/126 490 0.84 (0.79 to 0.89) 1090/128 217 0.85 (0.80 to 0.90) −0.01 (−0.08 to 0.06)
Secondary Outcome: Recall Rate
All screenings 24 681/596 642 4.14 (4.09 to 4.19) 24 894/597 505 4.17 (4.12 to 4.22) −0.03 (−0.10 to 0.04)
Previous attenders 14 819/470 152 3.15 (3.10 to 3.20) 14 869/469 288 3.17 (3.12 to 3.22) −0.02 (−0.09 to 0.05)
Previous nonattenders 9862/126 490 7.80 (7.65 to 7.94) 10 025/128 217 7.82 (7.67 to 7.97) −0.02 (−0.23 to 0.19)
Secondary Outcome: Disagreement Rate Between Readers
All screenings 20 471/596 294 3.43 (3.39 to 3.48) 20 793/597 387 3.48 (3.43 to 3.53) −0.05 (−0.11 to 0.02)
Previous attenders 12 850/469 869 2.73 (2.69 to 2.78) 12 937/469 215 2.76 (2.71 to 2.80) −0.02 (−0.09 to 0.04)
Previous nonattenders 7621/126 425 6.03 (5.90 to 6.16) 7856/128 172 6.13 (6.00 to 6.26) −0.10 (−0.29 to 0.08)
a Cancer detection rate, recall rate, and rate of disagreement between readers in screenings of previous attenders, screenings of previous nonattenders,
and all screenings.
Table 1. Baseline Characteristics for Intervention and Control Groups
Intervention Control
Individual level
Age of women screened, mean (SD), y 59.3 (7.48) 59.3 (7.49)
Had previously attended screening, Total/No. (%) 126 490/596 642 (21.2) 128 217/597 505 (21.5)
Cluster level, median (interquartile range)
Batch length 35 (16-46) 35 (16-45)
No. of screenings examined by each reader 2848 (1469-4385) 2891 (1543-4458)
No. of batches examined by each reader 86 (52-143) 91 (51-138)
No. of screenings examined at each center 12 496 (8997-16 523) 12 908 (9529-16 418)
No. of batches examined at each center 376 (282-502) 364 (272-521)
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or subsequent in eachworkdaybyboth readers, the recall rate
was4.10% (11 868of 289786; 95%CI, 4.02%-4.17%) in the in-
terventiongroupand4.15%(12068of290671;95%CI,4.08%-
4.22%) in the control group (difference, −0.06% points; 95%
CI, −0.16% to 0.05% points), and rate of disagreements was
3.23% (9359of 289785; 95%CI, 3.17%-3.29%) in the interven-
tion group and 3.28% (9533 of 290 670; 95% CI, 3.22%-
3.35%) in the control group (difference, −0.05% points; 95%
CI, −0.14% to 0.04% points).
Exploratory post hoc analysis showed that cancer detec-
tion rate for individual readers didnot changewith time spent
on task, as represented by near identical odds of detecting
cancer between the first and 40th case (OR, 0.987; 95% CI,
0.929-1.048). Results were very similar in the model ad-
justed for the characteristics of the woman screened (OR,
0.995; 95% CI, 0.938-1.055; eTable 5 in Supplement 2).
Exploratory post hoc analysis showed that recall rate for
individual readers (the proportion ofwomen that 1 reader de-
termined should be recalled) reduced with time on task. The
oddsof recall decreasedover the courseof examining40cases
(OR,0.83; 95%CI,0.81-0.85). The reductionwas similar in the
model adjusted forwoman’s ageandpreviousattendance (OR,
0.89; 95%CI, 0.87-0.91; eTable 6 in Supplement 2). Themean
change over the course of 40 cases was a reduction in recall
rate from6.4%(position 1) to4.6%(position40),with the trend
continuing in longer batches (Figure 3).
Further exploratorypost hoc analysis indicated that there
was also no effect of the intervention when readers were
blinded to one another’s decision. For all 366824 cases read
from the 16 centers, the second readerwas blinded to the first
reader’s decision results. In those centers, the cancer detec-
tion rate was 0.88% (1603 of 181 482; 95% CI, 0.84%-0.93%)
in the intervention group and 0.87% (1611 of 185 342; 95%CI,
0.83%-0.91%) in the control group (difference, 0.01% points;
95% CI, −0.05% to 0.07% points). Similarly recall rate was
4.23% (7669of 181 482; 95%CI, 4.13%-4.32%) in the interven-
tion group and 4.23% (7847 of 185 342; 95%CI, 4.14%-4.33%)
in thecontrolgroup (difference,−0.01%points;95%CI,−0.14%
to 0.12% points).
Discussion
This study examined whether an intervention to change the
order in which readers examine breast screening cases could
improve cancer detection rates. We randomized 1.2 million
women in batches of approximately 35 to either intervention
or control groups. The intervention did not influence cancer
detection rate, recall rate, or rate of disagreement between
readers. There was no pattern of decreasing cancer detection
Table 3. Factors AssociatedWith Cancer Detection Rate Identified
byMultilevel Logistic RegressionModels, Unadjusted and Adjusted
for Age and Previous Screening Attendance
Variable
Odd Ratio (95% CI)
Unadjusted Model Adjusted Model
Fixed-Effects (Measures of Association)
Treatment variable
Treatment vs control 1.01 (0.96-1.06) 1.01 (0.97-1.06)
Background factors
Age, per year of age 1.052 (1.048-1.055)
No previous attendance 1.73 (1.62-1.86)
Random-Effects (Measures of Variation)
Center level
Variance, SE 0.058 (0.012-0.104) 0.038 (0.011-0.064)
Intracenter correlation, % 1.39 0.96
Median OR 1.26 1.20
P value for Wald statistics .014 .006
Batch level
Variance, SE 0.809 (0.754-0.863) 0.595 (0.543-0.647)
Intrabatch correlation, % 20.85 16.13
Median OR 2.35 2.08
P value for Wald statistics <.001 <.001
Abbreviation: OR, odds ratio.
Figure 3. Average Patterns of Cancer Detection Rate and Recall Rate for a Single Reader Over the Course of Examining a Batch ofMammograms
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Each data point represents themean recall or cancer detection rate over all
cases examined by reader 1 at that position in the batch. A total of 1 173 930
cases were included, examined as reader 1 by 348 readers. Themedian number
of screenings per batch position is 21 931 (interquartile range, 10 133-28 126).
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ratewith timeontaskaspredictedbyprevious researchonvigi-
lance decrements as a psychological phenomenon. Instead
therewas a gradual decrease in recall rate,with an increase in
PPVandadecrease in false-positive recall ofwomenwith time
on task. This may reinforce and explain previous observa-
tional research that identifies that recall rate is reducedwhen
grouping women’s cases into batches.23
This randomized clinical trialwas adequately powered to
answer the research questions, with more than half of the
English breast screening service participating. Effects were
measured in a wide range of hospitals, increasing generaliz-
ability. Integration into the existing computer systems and re-
porting mechanisms resulted in very little loss to follow-up
(<0.1%).Designof the trial computer systemwas iterativewith
high user involvement, which increased practicality and fa-
cilitated recruitment.
This study has several limitations. First, the main limita-
tion is that reading conditions were not controlled, so al-
though effectiveness in screening practicewasmeasured, ef-
ficacy in ideal conditions was not evaluated. In this large
pragmatic trial, we aimed tomeasure the effects of the inter-
vention applied to current clinical practice in the United
Kingdom, andwedidnot control for ormeasureworking con-
ditions, some of which may affect whether there is a vigi-
lancedecrement. Second, all readerswouldhavemet themini-
mumNHSBSP standards for reading volume, althoughwedid
not specify ormeasure the lengthof each reader’sworkweek,
theproportionof his/her time spentworking in breast screen-
ingor readingmammograms, thenumberofworkhoursor type
of work activities each day, number of breaks taken, or self-
perceptions of fatigue. Similarly, although there are program-
wideauditingmethods for readerperformance,14 therewill also
be center-level variation inmanagement of individual perfor-
mance that we did not record. Third, the trial did not attempt
to implement blinding of reader 2 to the decision of reader 1
in centers inwhich this was not standard practice, as limiting
reader’s access to computerized andpaper noteswasnot con-
sideredpossiblewithout compromisingpatient safety.Fourth,
13% of women in the intervention group did not receive the
intervention as intended. The trial software automatically de-
tected these events, which occurred when readers manually
overrode the case order and revisited the same case or used
barcodes to identify individual cases. These womenwere in-
cluded in the intention to treat analysis.
The trial results were unexpected and contradict previ-
ous research on the vigilance decrement in other fields.5 The
vigilance decrement phenomenon has been reported in
many peer reviewed publications5 but was not observed in
this large randomized clinical trial. These previous studies
were primarily undertaken in psychology laboratories rather
than in real-life settings. Gur et al24 demonstrated that per-
formance in experimental conditions and in clinical practice
may be very different, suggesting that there is a very differ-
ent set of incentives in these 2 settings for the reader.
Hancock25 contends that the vigilance decrement is entirely a
phenomenon created by the conditions designed to measure
it. Another explanation for not observing any vigilance decre-
ment is simply that the sessions were too short; however,
batches of 40 cases take 20 to 30 minutes to examine,26 and
the vigilance decrement is usually complete 25 to 35 minutes
into the task.5 The experienced specialists in this study could
be less prone to a vigilance decrement, as was found in expe-
rienced closed caption television operators reviewing a test
film.27 The vigilance decrement phenomenon may be associ-
ated with an increase in recall threshold rather than a reduc-
tion in performance.28 If readers already have a low-recall
threshold so that they are recalling cases with minimal indi-
cations of cancer on the mammograms, this may translate to
an increase in specificity with minimal decrease in sensitiv-
ity. In addition, we have not yet tested the secondary out-
come of the interval cancer rate (rate of cancers detected
symptomatically between screening rounds). If there was a
pattern in number of interval cancers with time on task, then
this may provide evidence of a vigilance decrement. This will
be investigated through future analysis of 3-year follow-up
data. However, we are unlikely to observe such a pattern
because the interval cancer rate is inversely proportional to
the cancer detection rate and this does not change with time
on task, and because all cases recalled by one reader received
a reference standard of peers (independent examination by
another reader followed by examination by a third reader or
group of readers) and 60% received follow-up tests that
included ultrasound and biopsy as appropriate. Furthermore,
the increase in recall rate at the beginning of the batch is
many times larger than the total number of interval cancers
at screening.1
A reduction in recall rate with time spent on task has not
previously been observed in breast cancer screening. How-
ever, an observational study has indicated that examining
batches of women’s mammograms in one sitting, rather than
one by one reduces the overall recall rate with no change in
cancer detection rate.23
The systematic reduction in recall rate with time on task
for an individual reader did not translate into differences be-
tween the intervention and control group (double reading) in
overall recall rate or rate of disagreements between readers.
There are several possible explanations. The mechanism
of action is dependent on the increased recall rates acting on
the same cases in the control group and different cases in the
intervention group. However, the situation is complex. Dif-
ferent readers have different recall thresholds and have
different abilities to detect each type of mammographic ab-
normality (eg, spiculatedmasses, asymmetries, architectural
distortions). Furthermore, each mammogram has overlap-
ping tissue and many features that may appear suspicious.
Therefore, for any particular pair, the increase in cases re-
called at the beginning of the session may not manifest in
recalling the same cases. If this is the case, then the interven-
tionwouldnot affect overall recall rate but itwould affectwho
is recalled, withmorewomen recalled at the beginning of the
batch in the control groupandwith recalls spreadmoreevenly
throughout the batch in the intervention group.
The implications for practice are 2-fold. First the inter-
ventionof 2 readers examiningabatchofmammograms in the
opposite rather than the same order was not effective in
increasing cancer detection rate.We have found no evidence
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of harms from the intervention; however, some participating
readers reported that it was more difficult to examine cases
in reverse order because they also had to reverse associated
paperwork. This result is generalizable only to population
screening programs that use 2 readers to examine mammo-
grams separately. These include theUKNHS breast screening
programs forwhichdouble reading ofmammogramswas rec-
ommended and became mandatory following the transition
to fullydigitalmammography,14 Europeanpopulation screen-
ing program for which double reading is recommended and
implemented,29 and Australia where double reading is con-
sideredpreferable30because it increases sensitivity31 but isnot
mandated. In the United States, the Mammography Quality
Standards Act and the US Food and Drug Administration do
not require double reading of mammograms. The decision is
madebyprofessional societies and individual centers; inprac-
tice it rarely happens.
Second, for individual readers recall rate decreased with
time spent on task for up to 60 cases, with no concurrent
change in cancerdetection rate. Therefore,we suggest that ex-
amining cases in batches of up to 60 is likely to be beneficial.
This resultwas foundacross 360 readers, encompassingmore
thanhalf of theNHSBreast ScreeningProgramme inEngland.
Therefore, it is likely to be generalizable to screening in
England, andmaybe generalizable across all breast screening
programs using batch reading. Examining mammograms in
batches is now standard practice in high-volume population
breast screeningprogramsworldwide,withevidencethatbatch
reading increases specificity.23 However, batch reading is not
always used, particularlywhen case volumes are low, such as
inpractices serving smaller populations. Batch reading is rou-
tine for other imaging studiesnot involvingdirect radiologist-
patient contactwith radiology information systems designed
for this practice.
Conclusions
Interpretationofbatchesofmammogramsbyqualified screen-
ingmammography readersusing adifferent order vs the same
order for the second reading resulted in no significant differ-
ence in rates of detection of breast cancer.
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